BAKER BROS. ADVISORS LP

BAKER BROS. ADVISORS LP is an Investment Adviser institutional filer with the SEC under CIK 1263508, reporting 84 portfolio positions, with 19 historical 13F filings on file. Most recent reporting period: 2026-06-30.

A Form 13F reports a manager's US-listed stock and option positions only. It does not include real estate, private funds, bonds, cash or non-US holdings, so a 13F portfolio value is not the firm's total assets under management (AUM).

• State of incorporation: DE
• Filing type: 13F-HR
• Latest reporting period: 2026-06-30
• Last filed: 2026-08-14

Top 10 portfolio positions

The largest reported holdings in BAKER BROS. ADVISORS LP's most recent 13F filing, ranked by reported market value.

1. Incyte Corporation (INCY)
2. BeOne Medicines Ltd. (ONC)
3. Revolution Medicines, Inc. (RVMD)
4. Madrigal Pharmaceuticals, Inc. (MDGL)
5. ACADIA Pharmaceuticals Inc. (ACAD)
6. Kymera Therapeutics, Inc. (KYMR)
7. Insmed Incorporated (INSM)
8. Celcuity Inc. (CELC)
9. Kodiak Sciences Inc. (KOD)
10. Rhythm Pharmaceuticals, Inc. (RYTM)